The most rcent announcement highlighted the production testing program (revenue positive) for RGN1, expected to be run during Q3.
Although there seemed a very low key vibe to the upcoming process in that announcement, I believe the outcome is going to be of monumental consequence.
In the run down to the AGM, from the end of Q3, presumably the outcome of the production testing is all we can cling onto as possible progress.
Meanwhile, Lets hope the farm-in proposition might rise from the watery depths.
EGO Price at posting:
16.0¢ Sentiment: Hold Disclosure: Held